A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris

NCT01580488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: B LEO 35299 20 mg/g cream
DRUG: C LEO 35299 20 mg/g cream
DRUG: E LEO 35299 10 mg/g solution
DRUG: F LEO 35299 10 mg/g solution
DRUG: Daivonex® ointment
DRUG: Daivonex® ointment vehicle

Sponsor

LEO Pharma